Combination strategies based on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for cancer patients: Pooled analysis and subgroup analysis of efficacy and safety

BACKGROUND: Combination therapy based on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is an emerging trend in cancer treatment, but the clinical value of EGFR-TKIs combination therapy remains controversial. Thus, we conducted a comprehensive analysis of randomized contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ran, Shao, Hong, Zhu, Jing, Ju, Qianqian, Shi, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456063/
https://www.ncbi.nlm.nih.gov/pubmed/30921175
http://dx.doi.org/10.1097/MD.0000000000014135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456063/
https://www.ncbi.nlm.nih.gov/pubmed/30921175
http://dx.doi.org/10.1097/MD.0000000000014135

Ejemplares similares